Detailed Mechanism Funding and Narrative

Years of mechanism: 2013 2014

Details for Mechanism ID: 16459
Country/Region: India
Year: 2014
Main Partner: World Health Organization
Main Partner Program: NA
Organizational Type: Multi-lateral Agency
Funding Agency: USAID
Total Funding: $0 Additional Pipeline Funding: N/A

NOTE: The following is taken from summaries released by PEPFAR on the PEPFAR Data Dashboard. They are incomplete summary paragraphs only and do not contain the full mechanism details. When the full narratives are released, we will update the mechanism pages accordingly.

There are an estimated 2.1 million people living with HIV (PLHIV) in India. Tuberculosis (TB) accounts for 25% of deaths among PLHIV in India. Although only 5% of TB patients are HIV-infected, in absolute terms there are more than 100,000 cases annually, ranking second worldwide, with about 10% of the global HIV-associated TB burden.

This project supports PEPFAR/India’s Strategic Goal #1: Improved access to quality services/Technical Leadership and Innovation, through its objectives to: a) pilot intensified TB case finding in high burden antiretroviral therapy (ART) centers in selected states using innovative strategies and diagnostic algorithms, b) improve treatment outcomes of HIV-positive TB patients through early case finding, treatment with standard first line drugs using a quality assured daily regimen, and providing early ART, c) pilot feasibility of Isoniazid Preventive Therapy (IPT) among TB-negative PLHIV, and d) provide technical assessment and support for airborne infection control (AIC) at ART/ICTC sites

These objectives are articulated in the Government of India (GOI) National Framework for Joint HIV/TB Collaborative Activities. Interventions will be conducted at 40 ART/ICTC sites and will target PLHIV, TB/HIV co-infected and TB-negative patients attending ART centers. The project will help set up GeneXpert modules at the 40 sites enabling early diagnosis of TB among PLHIV. At project completion, modules will be transitioned to the GOI.

Monitoring and evaluation will be conducted by both programs (HIV and TB), with monthly and quarterly reporting that will include number of TB patients diagnosed at ART centers, TB treatment success rates, case fatality rates among PLHIV, and proportion of ART centers implementing acceptable levels of AIC.

Mechanism Allocation by Budget Code for Selected Year
Care: TB/HIV (HVTB) $0
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

This mechanism has no published performance targets or indicators.

Key Issues Identified in Mechanism
Tuberculosis